Professor Yang Shufang from Taizhou People’s Hospital Affiliated with Nanjing Medical University shared insights on the current management status of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Given that MASLD involves numerous risk factors including obesity, glycemic abnormalities, and metabolic disorders, its treatment requires multidisciplinary collaboration. Core therapeutic strategies focus on reducing body mass index (BMI) and […]